rss

Author index

August 2001, Volume 54, Issue 4

[Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Alvi, A J

    • Microsatellite instability and mutational analysis of transforming growth factor β receptor type II gene (TGFBR2) in sporadic ovarian cancer Mol Path 2001;54:240-243 doi:10.1136/mp.54.4.240

  2. Anthony, D D

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  3. Ariel, I

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

B

  1. Ball, R Y

    • Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Path 2001;54:275-280 doi:10.1136/mp.54.4.275

  2. Bernheim, A

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

  3. Broggini, M

    • Microsatellite instability and mutational analysis of transforming growth factor β receptor type II gene (TGFBR2) in sporadic ovarian cancer Mol Path 2001;54:240-243 doi:10.1136/mp.54.4.240

C

  1. Cadot, B

    • Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Path 2001;54:275-280 doi:10.1136/mp.54.4.275

  2. Casey, G

    • Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers Mol Path 2001;54:259-263 doi:10.1136/mp.54.4.259

  3. Curran, S

    • Application of laser capture microdissection and proteomics in colon cancer Mol Path 2001;54:253-258 doi:10.1136/mp.54.4.253

D

  1. Darlington, G

    • Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers Mol Path 2001;54:259-263 doi:10.1136/mp.54.4.259

  2. Davison, S

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

  3. Dejean, A

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

  4. Duc, H T

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  5. Duverger, A

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

E

  1. Edwards, D R

    • Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Path 2001;54:275-280 doi:10.1136/mp.54.4.275

F

  1. Fellig, Y

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

  2. Fothergill, J E

    • Application of laser capture microdissection and proteomics in colon cancer Mol Path 2001;54:253-258 doi:10.1136/mp.54.4.253

  3. François, J-C

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

H

  1. Henin, D

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  2. Herrington, C S

    • What we could do now: molecular pathology of gynaecological cancer Mol Path 2001;54:222-224 doi:10.1136/mp.54.4.222

  3. Hochberg, A

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

  4. Houlston, R S

    • What we could do now: molecular pathology of colorectal cancer Mol Path 2001;54:206-214 doi:10.1136/mp.54.4.206

I

  1. Ilyas, M

    • Molecular pathology of solid tumours: some practical suggestions for translating research into clinical practice Mol Path 2001;54:203-205 doi:10.1136/mp.54.4.203

J

  1. Jung, A

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

K

  1. Kalamarides, M

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  2. Kane, A

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  3. Kelly, D

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

  4. Knowles, M A

    • What we could do now: molecular pathology of bladder cancer Mol Path 2001;54:215-221 doi:10.1136/mp.54.4.215

L

  1. Latif, F

    • Microsatellite instability and mutational analysis of transforming growth factor β receptor type II gene (TGFBR2) in sporadic ovarian cancer Mol Path 2001;54:240-243 doi:10.1136/mp.54.4.240

  2. Lawrie, L C

    • Application of laser capture microdissection and proteomics in colon cancer Mol Path 2001;54:253-258 doi:10.1136/mp.54.4.253

  3. Leung, A S P

    • Identification of slide coagulase positive, tube coagulase negative Staphylococcus aureus by 16S ribosomal RNA gene sequencing Mol Path 2001;54:244-247 doi:10.1136/mp.54.4.244

  4. Leung, K W

    • Identification of slide coagulase positive, tube coagulase negative Staphylococcus aureus by 16S ribosomal RNA gene sequencing Mol Path 2001;54:244-247 doi:10.1136/mp.54.4.244

  5. Ly, A

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

M

  1. Maher, E R

    • Microsatellite instability and mutational analysis of transforming growth factor β receptor type II gene (TGFBR2) in sporadic ovarian cancer Mol Path 2001;54:240-243 doi:10.1136/mp.54.4.240

  2. Maillard, M

    • Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Path 2001;54:275-280 doi:10.1136/mp.54.4.275

  3. Marchio, A

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

  4. McLeod, H L

    • Application of laser capture microdissection and proteomics in colon cancer Mol Path 2001;54:253-258 doi:10.1136/mp.54.4.253

  5. Meddeb, M

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

  6. Meru, N

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

  7. Murray, G I

    • Application of laser capture microdissection and proteomics in colon cancer Mol Path 2001;54:253-258 doi:10.1136/mp.54.4.253

  8. Mutimer, D

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

N

  1. Niedobitek, G

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

  2. Noël, T

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

P

  1. Pan, Y

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  2. Perbal, B

    • Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Path 2001;54:275-280 doi:10.1136/mp.54.4.275

  3. Pineau, P

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

  4. Pizov, G

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

  5. Podeh, D

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

R

  1. Rader, J S

    • Microsatellite instability and mutational analysis of transforming growth factor β receptor type II gene (TGFBR2) in sporadic ovarian cancer Mol Path 2001;54:240-243 doi:10.1136/mp.54.4.240

  2. Rooney, N

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

S

  1. Sethia, K

    • Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Path 2001;54:275-280 doi:10.1136/mp.54.4.275

  2. Shevelev, A

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  3. Shochina, M

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

  4. Sughayer, M

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

T

  1. Tatoud, R

    • Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol Path 2001;54:275-280 doi:10.1136/mp.54.4.275

  2. Terris, B

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

  3. Tiollais, P

    • Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol Path 2001;54:270-274 doi:10.1136/mp.54.4.270

  4. Tomlinson, I

    • Molecular pathology of solid tumours: translating research into clinical practice. Introduction and overview Mol Path 2001;54:201-202 doi:10.1136/mp.54.4.201

  5. Tomlinson, I P M

    • Molecular pathology of solid tumours: some practical suggestions for translating research into clinical practice Mol Path 2001;54:203-205 doi:10.1136/mp.54.4.203

  6. Trojan, J

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  7. Trojan, L A

    • Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol Path 2001;54:230-239 doi:10.1136/mp.54.4.230

  8. Tubbs, R R

    • Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers Mol Path 2001;54:259-263 doi:10.1136/mp.54.4.259

  9. Turner, R D

    • Commissioning laboratory services Mol Path 2001;54:225-226 doi:10.1136/mp.54.4.225

V

  1. Vaziri, S A J

    • Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers Mol Path 2001;54:259-263 doi:10.1136/mp.54.4.259

  2. Vitner, K

    • Nitric oxide synthase immunoreactivity in human bladder carcinoma Mol Path 2001;54:248-252 doi:10.1136/mp.54.4.248

W

  1. Westphal, M

    • The IGF/IGFBP system in CNS malignancy Mol Path 2001;54:227-229 doi:10.1136/mp.54.4.227

  2. Whitehead, L

    • Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens Mol Path 2001;54:264-269 doi:10.1136/mp.54.4.264

  3. Woo, P C Y

    • Identification of slide coagulase positive, tube coagulase negative Staphylococcus aureus by 16S ribosomal RNA gene sequencing Mol Path 2001;54:244-247 doi:10.1136/mp.54.4.244

Y

  1. Yuen, K Y

    • Identification of slide coagulase positive, tube coagulase negative Staphylococcus aureus by 16S ribosomal RNA gene sequencing Mol Path 2001;54:244-247 doi:10.1136/mp.54.4.244

Z

  1. Zumkeller, W

    • The IGF/IGFBP system in CNS malignancy Mol Path 2001;54:227-229 doi:10.1136/mp.54.4.227

    • Pathology jobs

    Pathology jobs

    Show me all >>